2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Uterine Cervical Neoplasms
10
Neoplasms
9
Breast Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
5
Papillomavirus Infections
3
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Heart Diseases
2
HIV Infections
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
End Stage Liver Disease
2
the Rate of Participation in Screening for PBC
1
Warts
1
Venous Thromboembolism
1
Uterine Cervical Diseases
1
Urinary Bladder Neoplasms
1
Tinea
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Skin Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Interventions
Carboplatin
26
Etoposide
22
Vincristine
18
Melphalan
14
Filgrastim
14
Topotecan
11
Granulocyte Colony-Stimulating Factor
10
Cyclophosphamide
9
Thiotepa
7
Cryotherapy
7
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Drug Therapy
4
Busulfan
4
Radiotherapy
3
Ifosfamide
3
Doxorubicin
3
Brachytherapy
3
Watchful Waiting
2
Temozolomide
2
Platinum Compounds
2
Magnetic Resonance Imaging
2
Eye Enucleation
2
Cisplatin
2
Blood Specimen Collection
2
trioctyl phosphine oxide
1
sargramostim
1
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Mass Screening
×
Clear all
NCT06367569
2024-04-16
TRbFU
Amsterdam UMC, location VUmc
Completed
607 enrolled